Edition:
India

Clovis Oncology Announces European Commission Authorization Of Rubraca


Tuesday, 29 May 2018 

May 29 (Reuters) - Clovis Oncology Inc ::CLOVIS ONCOLOGY ANNOUNCES EUROPEAN COMMISSION AUTHORIZATION OF RUBRACA® (RUCAPARIB) FOR WOMEN WITH RECURRENT OVARIAN CANCER.CLOVIS ONCOLOGY INC - EC APPROVAL WAS BASED ON DATA FROM TWO MULTICENTER, SINGLE-ARM, OPEN-LABEL CLINICAL TRIALS.